Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Image-guided phenol genicular block for chronic pain due to knee osteoarthritis
RBR-4d3kvz5Recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of phenol and bupivacaine in knee osteoarthritis (OA) (2 arms), sponsored by Federal University of São Paulo. Started Dec 2022; status: recruiting.
02
Drugs
phenolbupivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-4d3kvz5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4d3kvz5.